First confirmed case of infant botulism in Africa, caused by a dual-toxin-producing Clostridium botulinum strain

Int J Infect Dis. 2021 Feb:103:164-166. doi: 10.1016/j.ijid.2020.11.131. Epub 2020 Nov 17.

Abstract

Botulism, a rare life-threatening toxemia, is probably underdiagnosed in all of its forms in Africa. This study reports the first laboratory-supported case of infant botulism on the African continent. A 10-week-old, previously well infant presented with progressive global weakness, feeding difficulty, and aspiration pneumonia. During a lengthy hospitalization, a rare bivalent Clostridium botulinum strain, producing subtype B3 and F8 toxins and with a new multilocus sequence type, was isolated from stool. The infant was successfully treated with a heptavalent botulinum antitoxin infusion and pyridostigmine. Despite the relative rarity of infant botulism, this case illustrates the importance of maintaining a high level of clinical suspicion when assessing hypotonic infants. The value of modern diagnostic modalities in identifying and characterizing this under-recognized condition is also demonstrated.

Keywords: Bivalent; Botulinum toxin; Clostridium botulinum; Infant botulism; South Africa.

Publication types

  • Case Reports

MeSH terms

  • Africa
  • Botulinum Toxins / biosynthesis
  • Botulism / diagnosis
  • Botulism / drug therapy
  • Botulism / microbiology*
  • Clostridium botulinum / isolation & purification*
  • Clostridium botulinum / metabolism
  • Hospitalization
  • Humans
  • Infant
  • Multilocus Sequence Typing

Substances

  • Botulinum Toxins